Neurological Disorders

+

Synaptys neuroscience

Lilly Moran, 25 March, 2025, 0

Synaptys neuroscience An innovative approach against Alzheimer’s disease

+

BCV

Lilly Moran, 25 March, 2025, 0

BCV Solving complex access in minimally invasive endovascular procedures

+

PIPRA

Lilly Moran, 11 March, 2025, 0

PIPRA Developing AI-powered tools to predict, prevent, and diagnose neurocognitive diseases.

+

Biometriks Health S.L.

Heidi Rohwer, 3 March, 2025, 0

Biometriks Health S.L. Pioneering Acquired Brain Injury NeuroRehab with Cutting-Edge Tech & Care

+

AXOLTIS PHARMA

Lilly Moran, 27 February, 2025, 0

AXOLTIS PHARMA Potential revolution in the treatment of neurodegenerative diseases

+

Bitsphi Diagnosis

Lilly Moran, 19 February, 2025, 0

Bitsphi Diagnosis EEG based biomarkers for ADHD and other cognitive disorders

+

DegenRx B.V.

Lilly Moran, 10 February, 2025, 0

DegenRx B.V. Developing of a highly specific, one-time treatment for Alzheimer’s disease patients

+

ABCDx

Lilly Moran, 10 February, 2025, 0

ABCDx Critical stroke management: saving lives within 10 mins

+

RonomA

Lilly Moran, 29 January, 2025, 0

RonomA Developing a new therapeutic approach to change the course of Alzheimer disease

+

Neurolieve Biosciences Ltd

Lilly Moran, 8 January, 2025, 0

Neurolieve Biosciences Ltd Neurolieve Biosciences aims to improve life quality for millions with peripheral neuropathic pain.

Synaptys neuroscience

BCV

PIPRA

Biometriks Health S.L.

AXOLTIS PHARMA

Bitsphi Diagnosis

DegenRx B.V.

ABCDx

RonomA

Neurolieve Biosciences Ltd

Capital Cell Barcelona

Links

About cookies

Neurological Disorders

Capital Cell Barcelona

Links

About cookies

Log in with your credentials

Forgot your details?

Create Account